13F filing recap · Q4 2007

What did Fairfax Financial Holdings buy in Q4 2007?

Reported stock-position changes between this filing and the previous one.

Stock value

$3.00B

Positions

Estimated turnover

10.7%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

LVLTLevel 3 Communications Inc$66.88Mreported value+22.00M shares AZNAstrazeneca Plc$544.0Kreported value+12.7K shares ODPThe Odp Corporation$303.0Kreported value+21.8K shares NEUNewmarket Corporation$223.0Kreported value+4.0K shares

Increased positions

DELLDell Technologies Inc.$245.69Mreported value+1.50M shares+17.6%KGKing Pharmaceuticals Inc$102.42Mreported value+8.97M shares+869.1%GSKGsk Plc$947.0Kreported value+10.0K shares+113.6%

Exited positions

MRSHMarsh & Mclennan Companies, Inc.$61.28Mprior reported value-2.40M shares-100.0%DOWDow Jones & Company$59.70Mprior reported value-1.00M shares-100.0%EMNEastman Chemical Co$3.34Mprior reported value-50.0K shares-100.0%BRK.BBerkshire Hathaway Inc$395.0Kprior reported value